Iron oxide nanoparticles and methods of use thereof
US-2018028417-A1 · Feb 1, 2018 · US
US12433295B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12433295-B2 |
| Application number | US-201917291326-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 25, 2019 |
| Priority date | Nov 28, 2018 |
| Publication date | Oct 7, 2025 |
| Grant date | Oct 7, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Systems and methods for eradicating biofilms by killing bacteria within a biofilm, degrading the matrix and removing biofilm debris are disclosed herein. The disclosed subject matter provides techniques for administering a suspension of H 2 O 2 and iron oxide nanoparticles to substantially eradicate bacteria within a biofilm matrix and degrade the bio film matrix, actuating the iron oxide nanoparticles for assembly into biohybrid robots suitable for removal of biofilm debris, and moving the biohybrid robots to remove the bio film debris from accessible or enclosed surfaces. In some embodiments, the disclosed subject matter can include embedding iron oxide nanoparticles in a hydrogel to form a soft robotic structure, administering the soft robotic structure to a biofilm-covered location, and magnetizing the soft robot structure to substantially eradicate bacteria within a biofilm matrix, degrade the biofilm matrix, and remove biofilm debris from enclosed surfaces.
Opening claim text (preview).
The invention claimed is: 1. A system for eradicating bacteria within a biofilm matrix, matrix degradation, and biofilm removal comprising: a suspension of H 2 O 2 and iron oxide nanoparticles, adapted to substantially eradicate the bacteria and degrade the biofilm matrix; wherein the iron oxide nanoparticles are embedded in a hydrogel to form a soft robotic structure configured to enable eradication of biofilm from confined locations; and a magnetic element, adapted to actuate the iron oxide nanoparticles by a magnetic field for assembly into biohybrid robots suitable for removal of biofilm debris caused by bacterial eradication and matrix degradation, wherein the soft robotic structure is vane-shaped or double helicoid-shaped, adapted to scrape and displace the biofilm debris from a wall of an enclosed surface. 2. The system of claim 1 , wherein the suspension comprises 2000 micrograms of iron oxide nanoparticles per milliliter of 50% glycerol. 3. The system of claim 2 , wherein the suspension comprises at least one enzyme, adapted to degrade the biofilm matrix. 4. The system of claim 3 , wherein the at least one enzyme includes mutanase and dextranase. 5. The system of claim 2 , wherein the suspension comprises 1% H 2 O 2 and 1.75 U/8.75 U mutanase/dextranase. 6. The system of claim 1 , wherein the magnetic element comprises at least one of a permanent magnet or an array of electromagnets, adapted to apply a magnetic field to the biofilm to actuate the iron oxide nanoparticles to assemble into biohybrid robots. 7. The system of claim 6 , wherein the permanent magnet moves the biohybrid robots, adapted to remove the biofilm debris from the biofilm matrix. 8. The system of claim 7 , wherein the suspension of H 2 O 2 and iron oxide nanoparticles is administered to a tooth canal for endodontic disinfection or biofilm removal. 9. The system of claim 7 , wherein the biohybrid robots are adapted to move through isthmuses to disrupt biofilm and remove the biofilm debris.
Glucanases · CPC title
in the form of particles {(H01F1/346, H01F1/348 and H01F1/38 take precedence)} · CPC title
Glucan endo-1,3-alpha-glucosidase (3.2.1.59) · CPC title
Dextranase (3.2.1.11) · CPC title
Dextranase (3.2.1.11) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.